Press Releases April 20, 2026 04:05 PM

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call

Strata Critical Medical announces Q1 2026 earnings release date and conference call details.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
SRTA

Strata Critical Medical, a leading provider of time-critical logistics and medical services to the U.S. healthcare industry, will release its first quarter 2026 financial results on May 6, 2026, before market open. The company will hold a conference call on the same day to discuss the results, featuring its co-CEOs and CFO.

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
SRTA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings for Q1 2026 to be released before market open on May 6, 2026.
  • Conference call hosted by Co-CEOs and CFO includes Q&A session for investors and stakeholders.
  • Strata operates a major air transport and surgical services network supporting organ transplant logistics and care in the U.S.

NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants.

To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call.

An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here. A replay of the webcast will be available for one year.

About Strata Critical Medical, Inc.

Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.

Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

For more information, visit www.srta.com.

Contacts
Mathew Schneider
[email protected]


Risks

  • Financial performance for Q1 2026 could differ from market expectations, impacting stock price.
  • Dependence on U.S. healthcare industry regulations and transplant hospital demand.
  • Operational risks inherent in time-critical medical logistics and organ recovery services.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026